SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TGEN - Targeted Genetics Corporation
TGEN 8.230+0.9%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (292)4/28/2000 11:23:00 PM
From: Mike McFarlandRead Replies (1) of 557
 
<Leadership in AAV production>

Pretty funky annual report--but I like it.

Reassurance that Tgen has an edge for the
production of AAV is found on page 14--the
backside of the transparent sheet between
the microscope and the life buoy artwork.

The claim is not new--here is something...
Targeted Genetics Collaborates With NIH (3/98)
"This collaboration resulted from, in
large part, our ability to make commercial
scale quantities of extremely pure rAAV vectors,
something that we believe clearly distinguishes
Targeted Genetics from other companies competing
in the gene therapy arena."

cf-web.org

Parking misc...

AAV vectors: is clinical success on the horizon?
stockton-press.co.uk

___________________
rohmhaas.com
TSKgel SP-NPR column
(Tgen once presented a poster, google cache still
has it)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext